ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentZugOrchard Therapeutics (Switzerland) GmbH
Orchard Therapeutics (Switzerland) GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Orchard Therapeutics (Switzerland) GmbH develops gene therapies for rare inherited diseases. Its work focuses on ex vivo HSC gene therapy, in which a patient’s own blood stem cells are genetically modified outside the body and then reinfused.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Orchard Therapeutics (Switzerland) GmbH

Pharmaceutical Industry
✓ Offered3
HSC gene therapy
HSC gene therapy for severe and other genetic diseases; platform based on haematopoietic stem cells, developed for areas with significant medical need.
Information for Families
Information on family experiences and diseases such as MLD; patient-focused content, stories and explanations about the treatment and the company’s purpose.
Information for Healthcare Professionals
Information for Healthcare Professionals on HSC gene therapy, the development approach and disease-specific content; professional resources and company information.
Trust & reputation

ranQ Trust Score of Orchard Therapeutics (Switzerland) GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Orchard Therapeutics (Switzerland) GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Orchard Therapeutics (Switzerland) GmbH scores 67.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.64.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Orchard Therapeutics (Switzerland) GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Orchard Therapeutics (Switzerland) GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Orchard Therapeutics (Switzerland) GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Orchard Therapeutics (Switzerland) GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Orchard Therapeutics (Switzerland) GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Orchard Therapeutics (Switzerland) GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Orchard Therapeutics (Switzerland) GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Untermüli 7
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-406.480.327
Founded
2021 · 5 years
Last commercial register change
March 26, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.88.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    DP
    Deciphera Pharmaceuticals (Schweiz) AG
    Zug
    SI
    Sarepta International Holdings GmbH
    Zug
    SR
    Scholar Rock Switzerland GmbH
    Zug
    AS
    Alnylam Switzerland GmbH
    Zug
    CT
    CRISPR Therapeutics AG
    Zug
    JP
    Jazz Pharmaceuticals Switzerland GmbH
    Zug
    CT
    Corcept Therapeutics Switzerland GmbH
    Zug
    AS
    Apellis Schweiz GmbH
    Zug